Theralase Technologies Inc. (CVE:TLT – Get Free Report) shares shot up 3.7% during mid-day trading on Tuesday . The stock traded as high as C$0.28 and last traded at C$0.28. Approximately 81,700 shares changed hands during mid-day trading, a decline of 68% from the average daily volume of 253,091 shares. The stock had previously closed at C$0.27.
Theralase Technologies Stock Up 1.9%
The company has a current ratio of 1.37, a quick ratio of 3.40 and a debt-to-equity ratio of 22.13. The stock’s 50-day moving average price is C$0.25 and its 200-day moving average price is C$0.26. The company has a market cap of C$81.31 million, a P/E ratio of -19.64 and a beta of -0.57.
Theralase Technologies Company Profile
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Featured Articles
- Five stocks we like better than Theralase Technologies
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
